Brilliant Blue G

DRUG4 trials

Sponsors

Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Kyusyu University Hospital, Ohshima Hospital of Ophthalmology, Asociación para Evitar la Ceguera en México, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Chromovitrevictomy for ERM and macular holeEpiretinal MembraneMacular HoleSurgerythe patients who will be performed vitreous surgery

Phase 1

Quantitative analysis of vitreous and plasma concentrations of brilliant blue G after use as a surgical adjuvant in chromovitrectomy

Active, not recruitingJPRN-UMIN000020216

Kyusyu University Hospital, Ohshima Hospital of OphthalmologyChromovitrevictomy for ERM and macular hole

Start: 2012-03-01Target: 5Updated: 2026-06-29

Phase 3

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

TerminatedNCT01820520

Asociación para Evitar la Ceguera en MéxicoEpiretinal Membrane, Macular Hole

Start: 2013-01-31End: 2014-02-28Updated: 2024-05-30

Unknown Phase

Hypothetical clinical trial for performance improvement of vitreous surgery by Brilliant Blue G intraocular staining

RecruitingJPRN-UMIN000007518

Department of Ophthalmology, Yamaguchi University Graduate School of Medicinethe patients who will be performed vitreous surgery

Start: 2011-01-01Target: 200Updated: 2026-06-29

Internal Limiting Membrane Peeling-reposition to Treat Idiopathic Macular Holes

CompletedNCT03020459

Xinhua Hospital, Shanghai Jiao Tong University School of MedicineMacular Hole, Surgery

Start: 2017-01-01End: 2019-08-01Updated: 2021-05-13